(Q35162245)

6 August 2017

1 reference

title

Epibatidine: impact on nicotinic receptor research (English)

1 reference

6 August 2017

Małgorzata Dukat

1

1 reference

PubMed ID

12825833

6 August 2017

Richard A Glennon

series ordinal

2

1 reference

6 August 2017

1 June 2003

1 reference

Cellular and Molecular Neurobiology

6 August 2017

1 reference

6 August 2017

23

1 reference

6 August 2017

3

1 reference

6 August 2017

365-378

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1023692705700

6 August 2017

0 references

cites work

Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2'-substituted-3'-phenyl-5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Novel nicotinic antagonist

1 reference

12 December 2020

Synthesis and pharmacological characterization of novel analogues of the nicotinic acetylcholine receptor agonist (+/-)-UB-165.

1 reference

12 December 2020

2-, 5-, and 6-Halo-3-(2(S)-azetidinylmethoxy)pyridines: synthesis, affinity for nicotinic acetylcholine receptors, and molecular modeling.

1 reference

12 December 2020

Improving the nicotinic pharmacophore with a series of (Isoxazole)methylene-1-azacyclic compounds: synthesis, structure-activity relationship, and molecular modeling

1 reference

12 December 2020

Fluoro-norchloroepibatidine: preclinical assessment of acute toxicity.

1 reference

12 December 2020

Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2'-substituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Epibatidine analogues

1 reference

12 December 2020

Therapeutic potential of neuronal nicotinic acetylcholine receptor agonists as novel analgesics

1 reference

12 December 2020

Nicotinic acetylcholine receptors and imaging

1 reference

12 December 2020

Synthesis and biological evaluation at nicotinic acetylcholine receptors of N-arylalkyl- and N-aryl-7-azabicyclo[2.2.1]heptanes

1 reference

12 December 2020

The pharmacological basis of contemporary pain management

1 reference

12 December 2020

Stereoselectivity of nicotinic receptors

1 reference

12 December 2020

Agonists at the alpha4beta2 nicotinic acetylcholine receptors: structure-activity relationships and molecular modelling

1 reference

12 December 2020

Epibatidine, a potent analgetic and nicotinic agonist.

1 reference

12 December 2020

Synthesis and evaluation of a novel series of 2-chloro-5-((1-methyl-2-(S)-pyrrolidinyl)methoxy)-3-(2-(4-pyridinyl)vinyl)pyridine analogues as potential positron emission tomography imaging agents for nicotinic acetylcholine receptors

1 reference

12 December 2020

(-)6-n-Propylnicotine antagonizes the antinociceptive effects of (-)nicotine

1 reference

12 December 2020

An improved nicotinic pharmacophore and a stereoselective CoMFA-model for nicotinic agonists acting at the central nicotinic acetylcholine receptors labelled by

1 reference

12 December 2020

Novel potent ligands for the central nicotinic acetylcholine receptor: synthesis, receptor binding, and 3D-QSAR analysis

1 reference

12 December 2020

A novel human nicotinic receptor subunit, alpha10, that confers functionality to the alpha9-subunit

1 reference

12 December 2020

Alkaloids from frog skin: the discovery of epibatidine and the potential for developing novel non-opioid analgesics

1 reference

12 December 2020

The identification of novel structural compound classes exhibiting high affinity for neuronal nicotinic acetylcholine receptors and analgesic efficacy in preclinical models of pain.

1 reference

12 December 2020

The potential of subtype-selective neuronal nicotinic acetylcholine receptor agonists as therapeutic agents

1 reference

12 December 2020

Synthesis and evaluation of N-[11C]methylated analogues of epibatidine as tracers for positron emission tomographic studies of nicotinic acetylcholine receptors.

1 reference

12 December 2020

[125I]IPH, an epibatidine analog, binds with high affinity to neuronal nicotinic cholinergic receptors.

1 reference

12 December 2020

Antinociceptive and toxic effects of (+)-epibatidine oxalate attributable to nicotinic agonist activity

1 reference

12 December 2020

Ligands for in vivo imaging of nicotinic receptor subtypes in Alzheimer brain.

1 reference

12 December 2020

Synthesis and nicotinic activity of epiboxidine: an isoxazole analogue of epibatidine

1 reference

12 December 2020

Development of ligands for in vivo imaging of cerebral nicotinic receptors

1 reference

12 December 2020

Comparative studies of epibatidine derivatives [18F]NFEP and [18F]N-methyl-NFEP: kinetics, nicotine effect, and toxicity.

1 reference

12 December 2020

1 reference

12 December 2020

The ensemble approach to distance geometry: application to the nicotinic pharmacophore

1 reference

12 December 2020

Exploring the nature of molecular recognition in nicotinic acetylcholine receptors

1 reference

12 December 2020

Structure and activity of acetylcholine

1 reference

12 December 2020

Quantitative structure-activity relationships of nicotine analogues as neuronal nicotinic acetylcholine receptor ligands

1 reference

12 December 2020

Development of muscarinic analgesics derived from epibatidine: role of the M4 receptor subtype

1 reference

12 December 2020

Central nicotinic receptor ligands and pharmacophores

1 reference

12 December 2020

The therapeutic potential of nicotinic acetylcholine receptor agonists for pain control

1 reference

12 December 2020

The chemistry of poisons in amphibian skin

1 reference

12 December 2020

A new look at the neuronal nicotinic acetylcholine receptor pharmacophore

1 reference

12 December 2020

(+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors

1 reference

12 December 2020

Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1023692705700

1 reference

PubMed ID

12825833

Dimensions Publication ID

6 August 2017

0 references

1 reference

PubMed ID

12825833